nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—HTR6—Raloxifene—osteoporosis	0.148	0.247	CbGbCtD
Pimozide—CYP1A2—Estropipate—osteoporosis	0.047	0.0784	CbGbCtD
Pimozide—CYP3A7—Estradiol—osteoporosis	0.0349	0.0583	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0349	0.0583	CbGbCtD
Pimozide—ABCB1—Ethinyl Estradiol—osteoporosis	0.0265	0.0442	CbGbCtD
Pimozide—CYP2C19—Cholecalciferol—osteoporosis	0.0262	0.0438	CbGbCtD
Pimozide—CYP3A5—Estradiol—osteoporosis	0.0262	0.0438	CbGbCtD
Pimozide—CYP3A4—Estropipate—osteoporosis	0.0246	0.0411	CbGbCtD
Pimozide—CYP3A4—Calcitriol—osteoporosis	0.0246	0.0411	CbGbCtD
Pimozide—CYP1A2—Conjugated Estrogens—osteoporosis	0.0222	0.0371	CbGbCtD
Pimozide—CYP2C19—Estradiol—osteoporosis	0.0211	0.0353	CbGbCtD
Pimozide—CYP2D6—Cholecalciferol—osteoporosis	0.0199	0.0333	CbGbCtD
Pimozide—CYP3A4—Ergocalciferol—osteoporosis	0.0197	0.0329	CbGbCtD
Pimozide—CYP1A2—Estradiol—osteoporosis	0.0195	0.0326	CbGbCtD
Pimozide—ABCB1—Conjugated Estrogens—osteoporosis	0.0194	0.0324	CbGbCtD
Pimozide—ABCB1—Estradiol—osteoporosis	0.0171	0.0285	CbGbCtD
Pimozide—CYP3A4—Raloxifene—osteoporosis	0.0164	0.0274	CbGbCtD
Pimozide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0159	0.0265	CbGbCtD
Pimozide—CYP3A4—Cholecalciferol—osteoporosis	0.0127	0.0212	CbGbCtD
Pimozide—CYP3A4—Conjugated Estrogens—osteoporosis	0.0116	0.0194	CbGbCtD
Pimozide—CYP3A4—Estradiol—osteoporosis	0.0102	0.0171	CbGbCtD
Pimozide—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00045	0.00201	CcSEcCtD
Pimozide—Eye disorder—Conjugated Estrogens—osteoporosis	0.000447	0.002	CcSEcCtD
Pimozide—Syncope—Risedronate—osteoporosis	0.000447	0.002	CcSEcCtD
Pimozide—Insomnia—Ibandronate—osteoporosis	0.000446	0.002	CcSEcCtD
Pimozide—Gastrointestinal disorder—Estropipate—osteoporosis	0.000444	0.00199	CcSEcCtD
Pimozide—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000444	0.00199	CcSEcCtD
Pimozide—Pollakiuria—Estradiol—osteoporosis	0.000442	0.00198	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00044	0.00197	CcSEcCtD
Pimozide—Constipation—Estropipate—osteoporosis	0.00044	0.00197	CcSEcCtD
Pimozide—Loss of consciousness—Risedronate—osteoporosis	0.000438	0.00196	CcSEcCtD
Pimozide—Anaemia—Pamidronate—osteoporosis	0.000438	0.00196	CcSEcCtD
Pimozide—Insomnia—Calcitriol—osteoporosis	0.000437	0.00196	CcSEcCtD
Pimozide—Weight increased—Estradiol—osteoporosis	0.000436	0.00195	CcSEcCtD
Pimozide—Mental disorder—Zoledronate—osteoporosis	0.000436	0.00195	CcSEcCtD
Pimozide—Agitation—Pamidronate—osteoporosis	0.000435	0.00195	CcSEcCtD
Pimozide—Constipation—Alendronate—osteoporosis	0.000434	0.00194	CcSEcCtD
Pimozide—Weight decreased—Estradiol—osteoporosis	0.000433	0.00194	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000432	0.00193	CcSEcCtD
Pimozide—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00043	0.00193	CcSEcCtD
Pimozide—Hypertension—Risedronate—osteoporosis	0.00043	0.00193	CcSEcCtD
Pimozide—Somnolence—Calcitriol—osteoporosis	0.00043	0.00192	CcSEcCtD
Pimozide—Decreased appetite—Ibandronate—osteoporosis	0.000429	0.00192	CcSEcCtD
Pimozide—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000426	0.00191	CcSEcCtD
Pimozide—Depression—Estradiol—osteoporosis	0.000426	0.0019	CcSEcCtD
Pimozide—Syncope—Pamidronate—osteoporosis	0.000425	0.0019	CcSEcCtD
Pimozide—Chest pain—Risedronate—osteoporosis	0.000424	0.0019	CcSEcCtD
Pimozide—Myalgia—Risedronate—osteoporosis	0.000424	0.0019	CcSEcCtD
Pimozide—Leukopenia—Pamidronate—osteoporosis	0.000424	0.0019	CcSEcCtD
Pimozide—Constipation—Ibandronate—osteoporosis	0.000422	0.00189	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000421	0.00189	CcSEcCtD
Pimozide—Pruritus—Etidronic acid—osteoporosis	0.000421	0.00188	CcSEcCtD
Pimozide—Decreased appetite—Calcitriol—osteoporosis	0.00042	0.00188	CcSEcCtD
Pimozide—Mental disorder—Conjugated Estrogens—osteoporosis	0.000419	0.00188	CcSEcCtD
Pimozide—Loss of consciousness—Pamidronate—osteoporosis	0.000416	0.00186	CcSEcCtD
Pimozide—Muscle spasms—Zoledronate—osteoporosis	0.000416	0.00186	CcSEcCtD
Pimozide—Dry mouth—Risedronate—osteoporosis	0.000415	0.00186	CcSEcCtD
Pimozide—Constipation—Calcitriol—osteoporosis	0.000413	0.00185	CcSEcCtD
Pimozide—Convulsion—Pamidronate—osteoporosis	0.000411	0.00184	CcSEcCtD
Pimozide—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000409	0.00183	CcSEcCtD
Pimozide—Hypertension—Pamidronate—osteoporosis	0.000409	0.00183	CcSEcCtD
Pimozide—Urticaria—Estropipate—osteoporosis	0.000409	0.00183	CcSEcCtD
Pimozide—Vision blurred—Zoledronate—osteoporosis	0.000408	0.00183	CcSEcCtD
Pimozide—Diarrhoea—Etidronic acid—osteoporosis	0.000407	0.00182	CcSEcCtD
Pimozide—Tremor—Zoledronate—osteoporosis	0.000405	0.00181	CcSEcCtD
Pimozide—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000405	0.00181	CcSEcCtD
Pimozide—Myalgia—Pamidronate—osteoporosis	0.000403	0.00181	CcSEcCtD
Pimozide—Urticaria—Alendronate—osteoporosis	0.000403	0.0018	CcSEcCtD
Pimozide—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000401	0.00179	CcSEcCtD
Pimozide—Shock—Risedronate—osteoporosis	0.0004	0.00179	CcSEcCtD
Pimozide—Anaemia—Zoledronate—osteoporosis	0.0004	0.00179	CcSEcCtD
Pimozide—Nervous system disorder—Risedronate—osteoporosis	0.000399	0.00179	CcSEcCtD
Pimozide—Agitation—Zoledronate—osteoporosis	0.000398	0.00178	CcSEcCtD
Pimozide—Skin disorder—Risedronate—osteoporosis	0.000395	0.00177	CcSEcCtD
Pimozide—Vision blurred—Conjugated Estrogens—osteoporosis	0.000393	0.00176	CcSEcCtD
Pimozide—Urticaria—Ibandronate—osteoporosis	0.000392	0.00175	CcSEcCtD
Pimozide—Syncope—Zoledronate—osteoporosis	0.000388	0.00174	CcSEcCtD
Pimozide—Leukopenia—Zoledronate—osteoporosis	0.000387	0.00173	CcSEcCtD
Pimozide—Urticaria—Calcitriol—osteoporosis	0.000384	0.00172	CcSEcCtD
Pimozide—Palpitations—Zoledronate—osteoporosis	0.000382	0.00171	CcSEcCtD
Pimozide—Shock—Pamidronate—osteoporosis	0.00038	0.0017	CcSEcCtD
Pimozide—Loss of consciousness—Zoledronate—osteoporosis	0.00038	0.0017	CcSEcCtD
Pimozide—Nervous system disorder—Pamidronate—osteoporosis	0.000379	0.0017	CcSEcCtD
Pimozide—Vomiting—Etidronic acid—osteoporosis	0.000378	0.00169	CcSEcCtD
Pimozide—Tachycardia—Pamidronate—osteoporosis	0.000377	0.00169	CcSEcCtD
Pimozide—Connective tissue disorder—Estradiol—osteoporosis	0.000376	0.00169	CcSEcCtD
Pimozide—Rash—Etidronic acid—osteoporosis	0.000375	0.00168	CcSEcCtD
Pimozide—Convulsion—Zoledronate—osteoporosis	0.000375	0.00168	CcSEcCtD
Pimozide—Dermatitis—Etidronic acid—osteoporosis	0.000375	0.00168	CcSEcCtD
Pimozide—Hyperhidrosis—Pamidronate—osteoporosis	0.000374	0.00167	CcSEcCtD
Pimozide—Syncope—Conjugated Estrogens—osteoporosis	0.000374	0.00167	CcSEcCtD
Pimozide—Hypertension—Zoledronate—osteoporosis	0.000374	0.00167	CcSEcCtD
Pimozide—Headache—Etidronic acid—osteoporosis	0.000373	0.00167	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000371	0.00166	CcSEcCtD
Pimozide—Asthenia—Estropipate—osteoporosis	0.000369	0.00165	CcSEcCtD
Pimozide—Visual impairment—Estradiol—osteoporosis	0.000369	0.00165	CcSEcCtD
Pimozide—Anorexia—Pamidronate—osteoporosis	0.000369	0.00165	CcSEcCtD
Pimozide—Chest pain—Zoledronate—osteoporosis	0.000368	0.00165	CcSEcCtD
Pimozide—Myalgia—Zoledronate—osteoporosis	0.000368	0.00165	CcSEcCtD
Pimozide—Palpitations—Conjugated Estrogens—osteoporosis	0.000368	0.00165	CcSEcCtD
Pimozide—Insomnia—Risedronate—osteoporosis	0.000368	0.00165	CcSEcCtD
Pimozide—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000366	0.00164	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000366	0.00164	CcSEcCtD
Pimozide—Pruritus—Estropipate—osteoporosis	0.000364	0.00163	CcSEcCtD
Pimozide—Asthenia—Alendronate—osteoporosis	0.000364	0.00163	CcSEcCtD
Pimozide—Hypotension—Pamidronate—osteoporosis	0.000361	0.00162	CcSEcCtD
Pimozide—Convulsion—Conjugated Estrogens—osteoporosis	0.000361	0.00162	CcSEcCtD
Pimozide—Dry mouth—Zoledronate—osteoporosis	0.00036	0.00161	CcSEcCtD
Pimozide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00036	0.00161	CcSEcCtD
Pimozide—Pruritus—Alendronate—osteoporosis	0.000359	0.00161	CcSEcCtD
Pimozide—Eye disorder—Estradiol—osteoporosis	0.000358	0.0016	CcSEcCtD
Pimozide—Constipation—Ethinyl Estradiol—osteoporosis	0.000357	0.0016	CcSEcCtD
Pimozide—Cardiac disorder—Estradiol—osteoporosis	0.000356	0.00159	CcSEcCtD
Pimozide—Chest pain—Conjugated Estrogens—osteoporosis	0.000355	0.00159	CcSEcCtD
Pimozide—Myalgia—Conjugated Estrogens—osteoporosis	0.000355	0.00159	CcSEcCtD
Pimozide—Asthenia—Ibandronate—osteoporosis	0.000354	0.00158	CcSEcCtD
Pimozide—Nausea—Etidronic acid—osteoporosis	0.000353	0.00158	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000352	0.00158	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000352	0.00158	CcSEcCtD
Pimozide—Diarrhoea—Estropipate—osteoporosis	0.000352	0.00158	CcSEcCtD
Pimozide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000351	0.00157	CcSEcCtD
Pimozide—Insomnia—Pamidronate—osteoporosis	0.00035	0.00157	CcSEcCtD
Pimozide—Pruritus—Ibandronate—osteoporosis	0.000349	0.00156	CcSEcCtD
Pimozide—Constipation—Risedronate—osteoporosis	0.000348	0.00156	CcSEcCtD
Pimozide—Shock—Zoledronate—osteoporosis	0.000347	0.00156	CcSEcCtD
Pimozide—Diarrhoea—Alendronate—osteoporosis	0.000347	0.00155	CcSEcCtD
Pimozide—Asthenia—Calcitriol—osteoporosis	0.000347	0.00155	CcSEcCtD
Pimozide—Nervous system disorder—Zoledronate—osteoporosis	0.000346	0.00155	CcSEcCtD
Pimozide—Tachycardia—Zoledronate—osteoporosis	0.000345	0.00154	CcSEcCtD
Pimozide—Somnolence—Pamidronate—osteoporosis	0.000344	0.00154	CcSEcCtD
Pimozide—Skin disorder—Zoledronate—osteoporosis	0.000343	0.00154	CcSEcCtD
Pimozide—Pruritus—Calcitriol—osteoporosis	0.000342	0.00153	CcSEcCtD
Pimozide—Hyperhidrosis—Zoledronate—osteoporosis	0.000341	0.00153	CcSEcCtD
Pimozide—Diarrhoea—Raloxifene—osteoporosis	0.000341	0.00153	CcSEcCtD
Pimozide—Dizziness—Estropipate—osteoporosis	0.00034	0.00152	CcSEcCtD
Pimozide—Diarrhoea—Ibandronate—osteoporosis	0.000338	0.00151	CcSEcCtD
Pimozide—Anorexia—Zoledronate—osteoporosis	0.000337	0.00151	CcSEcCtD
Pimozide—Decreased appetite—Pamidronate—osteoporosis	0.000336	0.0015	CcSEcCtD
Pimozide—Mental disorder—Estradiol—osteoporosis	0.000336	0.0015	CcSEcCtD
Pimozide—Dizziness—Alendronate—osteoporosis	0.000335	0.0015	CcSEcCtD
Pimozide—Shock—Conjugated Estrogens—osteoporosis	0.000335	0.0015	CcSEcCtD
Pimozide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000334	0.00149	CcSEcCtD
Pimozide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000334	0.00149	CcSEcCtD
Pimozide—Tachycardia—Conjugated Estrogens—osteoporosis	0.000332	0.00149	CcSEcCtD
Pimozide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000331	0.00148	CcSEcCtD
Pimozide—Constipation—Pamidronate—osteoporosis	0.000331	0.00148	CcSEcCtD
Pimozide—Diarrhoea—Calcitriol—osteoporosis	0.000331	0.00148	CcSEcCtD
Pimozide—Skin disorder—Conjugated Estrogens—osteoporosis	0.00033	0.00148	CcSEcCtD
Pimozide—Hypotension—Zoledronate—osteoporosis	0.00033	0.00148	CcSEcCtD
Pimozide—Dizziness—Raloxifene—osteoporosis	0.00033	0.00148	CcSEcCtD
Pimozide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000329	0.00147	CcSEcCtD
Pimozide—Vomiting—Estropipate—osteoporosis	0.000327	0.00146	CcSEcCtD
Pimozide—Dizziness—Ibandronate—osteoporosis	0.000326	0.00146	CcSEcCtD
Pimozide—Rash—Estropipate—osteoporosis	0.000325	0.00145	CcSEcCtD
Pimozide—Dermatitis—Estropipate—osteoporosis	0.000324	0.00145	CcSEcCtD
Pimozide—Anorexia—Conjugated Estrogens—osteoporosis	0.000324	0.00145	CcSEcCtD
Pimozide—Urticaria—Risedronate—osteoporosis	0.000323	0.00145	CcSEcCtD
Pimozide—Headache—Estropipate—osteoporosis	0.000322	0.00144	CcSEcCtD
Pimozide—Vomiting—Alendronate—osteoporosis	0.000322	0.00144	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000322	0.00144	CcSEcCtD
Pimozide—Muscle spasms—Estradiol—osteoporosis	0.000321	0.00144	CcSEcCtD
Pimozide—Rash—Alendronate—osteoporosis	0.00032	0.00143	CcSEcCtD
Pimozide—Insomnia—Zoledronate—osteoporosis	0.000319	0.00143	CcSEcCtD
Pimozide—Dermatitis—Alendronate—osteoporosis	0.000319	0.00143	CcSEcCtD
Pimozide—Hypotension—Conjugated Estrogens—osteoporosis	0.000318	0.00142	CcSEcCtD
Pimozide—Headache—Alendronate—osteoporosis	0.000318	0.00142	CcSEcCtD
Pimozide—Vomiting—Raloxifene—osteoporosis	0.000317	0.00142	CcSEcCtD
Pimozide—Rash—Raloxifene—osteoporosis	0.000314	0.00141	CcSEcCtD
Pimozide—Dermatitis—Raloxifene—osteoporosis	0.000314	0.00141	CcSEcCtD
Pimozide—Somnolence—Zoledronate—osteoporosis	0.000314	0.00141	CcSEcCtD
Pimozide—Vomiting—Ibandronate—osteoporosis	0.000314	0.0014	CcSEcCtD
Pimozide—Tremor—Estradiol—osteoporosis	0.000312	0.0014	CcSEcCtD
Pimozide—Headache—Raloxifene—osteoporosis	0.000312	0.0014	CcSEcCtD
Pimozide—Rash—Ibandronate—osteoporosis	0.000311	0.00139	CcSEcCtD
Pimozide—Dermatitis—Ibandronate—osteoporosis	0.000311	0.00139	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00031	0.00139	CcSEcCtD
Pimozide—Headache—Ibandronate—osteoporosis	0.000309	0.00138	CcSEcCtD
Pimozide—Insomnia—Conjugated Estrogens—osteoporosis	0.000308	0.00138	CcSEcCtD
Pimozide—Vomiting—Calcitriol—osteoporosis	0.000307	0.00137	CcSEcCtD
Pimozide—Decreased appetite—Zoledronate—osteoporosis	0.000307	0.00137	CcSEcCtD
Pimozide—Agitation—Estradiol—osteoporosis	0.000306	0.00137	CcSEcCtD
Pimozide—Nausea—Estropipate—osteoporosis	0.000306	0.00137	CcSEcCtD
Pimozide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000305	0.00136	CcSEcCtD
Pimozide—Rash—Calcitriol—osteoporosis	0.000305	0.00136	CcSEcCtD
Pimozide—Dermatitis—Calcitriol—osteoporosis	0.000304	0.00136	CcSEcCtD
Pimozide—Headache—Calcitriol—osteoporosis	0.000303	0.00135	CcSEcCtD
Pimozide—Somnolence—Conjugated Estrogens—osteoporosis	0.000302	0.00135	CcSEcCtD
Pimozide—Constipation—Zoledronate—osteoporosis	0.000302	0.00135	CcSEcCtD
Pimozide—Nausea—Alendronate—osteoporosis	0.000301	0.00135	CcSEcCtD
Pimozide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000299	0.00134	CcSEcCtD
Pimozide—Syncope—Estradiol—osteoporosis	0.000299	0.00134	CcSEcCtD
Pimozide—Nausea—Raloxifene—osteoporosis	0.000296	0.00133	CcSEcCtD
Pimozide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000296	0.00132	CcSEcCtD
Pimozide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000295	0.00132	CcSEcCtD
Pimozide—Palpitations—Estradiol—osteoporosis	0.000295	0.00132	CcSEcCtD
Pimozide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000294	0.00131	CcSEcCtD
Pimozide—Nausea—Ibandronate—osteoporosis	0.000293	0.00131	CcSEcCtD
Pimozide—Loss of consciousness—Estradiol—osteoporosis	0.000293	0.00131	CcSEcCtD
Pimozide—Asthenia—Risedronate—osteoporosis	0.000292	0.00131	CcSEcCtD
Pimozide—Constipation—Conjugated Estrogens—osteoporosis	0.000291	0.0013	CcSEcCtD
Pimozide—Hypertension—Estradiol—osteoporosis	0.000288	0.00129	CcSEcCtD
Pimozide—Pruritus—Risedronate—osteoporosis	0.000288	0.00129	CcSEcCtD
Pimozide—Nausea—Calcitriol—osteoporosis	0.000287	0.00128	CcSEcCtD
Pimozide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000285	0.00128	CcSEcCtD
Pimozide—Chest pain—Estradiol—osteoporosis	0.000284	0.00127	CcSEcCtD
Pimozide—Myalgia—Estradiol—osteoporosis	0.000284	0.00127	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000282	0.00126	CcSEcCtD
Pimozide—Urticaria—Zoledronate—osteoporosis	0.000281	0.00126	CcSEcCtD
Pimozide—Diarrhoea—Risedronate—osteoporosis	0.000278	0.00125	CcSEcCtD
Pimozide—Dry mouth—Estradiol—osteoporosis	0.000278	0.00124	CcSEcCtD
Pimozide—Asthenia—Pamidronate—osteoporosis	0.000277	0.00124	CcSEcCtD
Pimozide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000276	0.00123	CcSEcCtD
Pimozide—Pruritus—Pamidronate—osteoporosis	0.000274	0.00122	CcSEcCtD
Pimozide—Urticaria—Conjugated Estrogens—osteoporosis	0.00027	0.00121	CcSEcCtD
Pimozide—Dizziness—Risedronate—osteoporosis	0.000269	0.0012	CcSEcCtD
Pimozide—Shock—Estradiol—osteoporosis	0.000268	0.0012	CcSEcCtD
Pimozide—Nervous system disorder—Estradiol—osteoporosis	0.000267	0.00119	CcSEcCtD
Pimozide—Tachycardia—Estradiol—osteoporosis	0.000266	0.00119	CcSEcCtD
Pimozide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000265	0.00119	CcSEcCtD
Pimozide—Diarrhoea—Pamidronate—osteoporosis	0.000265	0.00118	CcSEcCtD
Pimozide—Skin disorder—Estradiol—osteoporosis	0.000264	0.00118	CcSEcCtD
Pimozide—Hyperhidrosis—Estradiol—osteoporosis	0.000263	0.00118	CcSEcCtD
Pimozide—Rash—Ethinyl Estradiol—osteoporosis	0.000263	0.00118	CcSEcCtD
Pimozide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000263	0.00118	CcSEcCtD
Pimozide—Headache—Ethinyl Estradiol—osteoporosis	0.000261	0.00117	CcSEcCtD
Pimozide—Vomiting—Risedronate—osteoporosis	0.000259	0.00116	CcSEcCtD
Pimozide—Rash—Risedronate—osteoporosis	0.000256	0.00115	CcSEcCtD
Pimozide—Dermatitis—Risedronate—osteoporosis	0.000256	0.00115	CcSEcCtD
Pimozide—Dizziness—Pamidronate—osteoporosis	0.000256	0.00114	CcSEcCtD
Pimozide—Headache—Risedronate—osteoporosis	0.000255	0.00114	CcSEcCtD
Pimozide—Asthenia—Zoledronate—osteoporosis	0.000253	0.00113	CcSEcCtD
Pimozide—Pruritus—Zoledronate—osteoporosis	0.00025	0.00112	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000248	0.00111	CcSEcCtD
Pimozide—Nausea—Ethinyl Estradiol—osteoporosis	0.000248	0.00111	CcSEcCtD
Pimozide—Insomnia—Estradiol—osteoporosis	0.000246	0.0011	CcSEcCtD
Pimozide—Vomiting—Pamidronate—osteoporosis	0.000246	0.0011	CcSEcCtD
Pimozide—Asthenia—Conjugated Estrogens—osteoporosis	0.000244	0.00109	CcSEcCtD
Pimozide—Rash—Pamidronate—osteoporosis	0.000244	0.00109	CcSEcCtD
Pimozide—Dermatitis—Pamidronate—osteoporosis	0.000244	0.00109	CcSEcCtD
Pimozide—Headache—Pamidronate—osteoporosis	0.000242	0.00108	CcSEcCtD
Pimozide—Somnolence—Estradiol—osteoporosis	0.000242	0.00108	CcSEcCtD
Pimozide—Diarrhoea—Zoledronate—osteoporosis	0.000242	0.00108	CcSEcCtD
Pimozide—Nausea—Risedronate—osteoporosis	0.000242	0.00108	CcSEcCtD
Pimozide—Pruritus—Conjugated Estrogens—osteoporosis	0.000241	0.00108	CcSEcCtD
Pimozide—Decreased appetite—Estradiol—osteoporosis	0.000237	0.00106	CcSEcCtD
Pimozide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000235	0.00105	CcSEcCtD
Pimozide—Dizziness—Zoledronate—osteoporosis	0.000234	0.00105	CcSEcCtD
Pimozide—Constipation—Estradiol—osteoporosis	0.000233	0.00104	CcSEcCtD
Pimozide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000233	0.00104	CcSEcCtD
Pimozide—Nausea—Pamidronate—osteoporosis	0.00023	0.00103	CcSEcCtD
Pimozide—Dizziness—Conjugated Estrogens—osteoporosis	0.000225	0.00101	CcSEcCtD
Pimozide—Vomiting—Zoledronate—osteoporosis	0.000225	0.00101	CcSEcCtD
Pimozide—Rash—Zoledronate—osteoporosis	0.000223	0.000997	CcSEcCtD
Pimozide—Dermatitis—Zoledronate—osteoporosis	0.000222	0.000996	CcSEcCtD
Pimozide—Headache—Zoledronate—osteoporosis	0.000221	0.00099	CcSEcCtD
Pimozide—Vomiting—Conjugated Estrogens—osteoporosis	0.000216	0.000968	CcSEcCtD
Pimozide—Urticaria—Estradiol—osteoporosis	0.000216	0.000968	CcSEcCtD
Pimozide—Rash—Conjugated Estrogens—osteoporosis	0.000214	0.00096	CcSEcCtD
Pimozide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000214	0.000959	CcSEcCtD
Pimozide—Headache—Conjugated Estrogens—osteoporosis	0.000213	0.000954	CcSEcCtD
Pimozide—Nausea—Zoledronate—osteoporosis	0.00021	0.000939	CcSEcCtD
Pimozide—Nausea—Conjugated Estrogens—osteoporosis	0.000202	0.000904	CcSEcCtD
Pimozide—Asthenia—Estradiol—osteoporosis	0.000195	0.000874	CcSEcCtD
Pimozide—Pruritus—Estradiol—osteoporosis	0.000193	0.000862	CcSEcCtD
Pimozide—Diarrhoea—Estradiol—osteoporosis	0.000186	0.000834	CcSEcCtD
Pimozide—Dizziness—Estradiol—osteoporosis	0.00018	0.000806	CcSEcCtD
Pimozide—Vomiting—Estradiol—osteoporosis	0.000173	0.000775	CcSEcCtD
Pimozide—Rash—Estradiol—osteoporosis	0.000172	0.000768	CcSEcCtD
Pimozide—Dermatitis—Estradiol—osteoporosis	0.000171	0.000767	CcSEcCtD
Pimozide—Headache—Estradiol—osteoporosis	0.000171	0.000763	CcSEcCtD
Pimozide—Nausea—Estradiol—osteoporosis	0.000162	0.000724	CcSEcCtD
Pimozide—DRD3—Signaling Pathways—LEP—osteoporosis	1.21e-05	6.81e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PSMA2—osteoporosis	1.21e-05	6.8e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PSMA5—osteoporosis	1.21e-05	6.8e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CALCA—osteoporosis	1.2e-05	6.76e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CALCA—osteoporosis	1.2e-05	6.76e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IRS2—osteoporosis	1.2e-05	6.73e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IGF1—osteoporosis	1.2e-05	6.73e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6R—osteoporosis	1.19e-05	6.72e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.19e-05	6.71e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IGF1—osteoporosis	1.18e-05	6.63e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—ESR1—osteoporosis	1.17e-05	6.57e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MTHFR—osteoporosis	1.16e-05	6.53e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IRS2—osteoporosis	1.16e-05	6.51e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IRS2—osteoporosis	1.16e-05	6.51e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—ESR1—osteoporosis	1.16e-05	6.51e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ENO1—osteoporosis	1.16e-05	6.5e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.15e-05	6.47e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PSMA2—osteoporosis	1.14e-05	6.41e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PSMA5—osteoporosis	1.14e-05	6.41e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KL—osteoporosis	1.13e-05	6.35e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MTHFR—osteoporosis	1.12e-05	6.32e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MTHFR—osteoporosis	1.12e-05	6.32e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ACP5—osteoporosis	1.12e-05	6.29e-05	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—TGFB1—osteoporosis	1.11e-05	6.22e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IRS2—osteoporosis	1.1e-05	6.21e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—POMC—osteoporosis	1.1e-05	6.19e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KL—osteoporosis	1.09e-05	6.14e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KL—osteoporosis	1.09e-05	6.14e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IRS1—osteoporosis	1.09e-05	6.14e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.08e-05	6.09e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—POMC—osteoporosis	1.08e-05	6.08e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IRS1—osteoporosis	1.08e-05	6.08e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.08e-05	6.07e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6R—osteoporosis	1.07e-05	6.04e-05	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—TGFB1—osteoporosis	1.07e-05	6.02e-05	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—TGFB1—osteoporosis	1.07e-05	6.02e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IRS2—osteoporosis	1.07e-05	6.01e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IRS2—osteoporosis	1.07e-05	6.01e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.06e-05	5.99e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—POMC—osteoporosis	1.06e-05	5.99e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—POMC—osteoporosis	1.06e-05	5.99e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—ADCY5—osteoporosis	1.06e-05	5.99e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.06e-05	5.98e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—ADCY5—osteoporosis	1.06e-05	5.97e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—GPX1—osteoporosis	1.06e-05	5.97e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—GPX1—osteoporosis	1.06e-05	5.95e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—ADCY5—osteoporosis	1.06e-05	5.95e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.06e-05	5.94e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—LEP—osteoporosis	1.06e-05	5.94e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—GPX1—osteoporosis	1.05e-05	5.93e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—POMC—osteoporosis	1.05e-05	5.91e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—SPP1—osteoporosis	1.05e-05	5.89e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—ADCY5—osteoporosis	1.05e-05	5.88e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IRS1—osteoporosis	1.04e-05	5.88e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—POMC—osteoporosis	1.04e-05	5.85e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—TPI1—osteoporosis	1.04e-05	5.85e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6R—osteoporosis	1.04e-05	5.84e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6R—osteoporosis	1.04e-05	5.84e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.03e-05	5.8e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—SPP1—osteoporosis	1.03e-05	5.78e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6R—osteoporosis	1.02e-05	5.77e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—ADCY5—osteoporosis	1.02e-05	5.75e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—ADCY5—osteoporosis	1.02e-05	5.75e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—GPX1—osteoporosis	1.02e-05	5.73e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—GPX1—osteoporosis	1.02e-05	5.73e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6R—osteoporosis	1.01e-05	5.71e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—SPP1—osteoporosis	1.01e-05	5.69e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IGF1—osteoporosis	1.01e-05	5.68e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IRS1—osteoporosis	1.01e-05	5.68e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IRS1—osteoporosis	1.01e-05	5.68e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.01e-05	5.67e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—CYP19A1—osteoporosis	1e-05	5.65e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IGF1—osteoporosis	1e-05	5.63e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6R—osteoporosis	9.81e-06	5.52e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—CYP19A1—osteoporosis	9.81e-06	5.52e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ENO1—osteoporosis	9.79e-06	5.51e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—MTHFR—osteoporosis	9.79e-06	5.51e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—P4HB—osteoporosis	9.78e-06	5.5e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—MTHFR—osteoporosis	9.76e-06	5.49e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—MTHFR—osteoporosis	9.72e-06	5.47e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PSMA2—osteoporosis	9.65e-06	5.43e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PSMA5—osteoporosis	9.65e-06	5.43e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IRS1—osteoporosis	9.64e-06	5.42e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GAPDH—osteoporosis	9.6e-06	5.4e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6R—osteoporosis	9.49e-06	5.34e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6R—osteoporosis	9.49e-06	5.34e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IRS2—osteoporosis	9.47e-06	5.33e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IRS1—osteoporosis	9.42e-06	5.3e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—MTHFR—osteoporosis	9.41e-06	5.29e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—MTHFR—osteoporosis	9.41e-06	5.29e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—RAP1A—osteoporosis	9.35e-06	5.26e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IRS1—osteoporosis	9.33e-06	5.25e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IRS1—osteoporosis	9.33e-06	5.25e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IRS2—osteoporosis	9.32e-06	5.24e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IRS2—osteoporosis	9.3e-06	5.23e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—LEP—osteoporosis	9.27e-06	5.21e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CYP19A1—osteoporosis	9.24e-06	5.2e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IRS2—osteoporosis	9.15e-06	5.15e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—IL6—osteoporosis	9.14e-06	5.14e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—LEP—osteoporosis	9.12e-06	5.13e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—LEP—osteoporosis	9.1e-06	5.12e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—POMC—osteoporosis	9.07e-06	5.1e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6R—osteoporosis	9.06e-06	5.1e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—IL6—osteoporosis	9.01e-06	5.07e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—LEP—osteoporosis	8.95e-06	5.04e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—ESR1—osteoporosis	8.85e-06	4.98e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6R—osteoporosis	8.84e-06	4.98e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ADCY5—osteoporosis	8.84e-06	4.97e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6R—osteoporosis	8.76e-06	4.93e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6R—osteoporosis	8.76e-06	4.93e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IGF1—osteoporosis	8.72e-06	4.91e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—ESR1—osteoporosis	8.7e-06	4.9e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—ESR1—osteoporosis	8.69e-06	4.89e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SPP1—osteoporosis	8.55e-06	4.81e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ADCY5—osteoporosis	8.55e-06	4.81e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ADCY5—osteoporosis	8.55e-06	4.81e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—ESR1—osteoporosis	8.55e-06	4.81e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SPP1—osteoporosis	8.27e-06	4.65e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SPP1—osteoporosis	8.27e-06	4.65e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IRS1—osteoporosis	8.27e-06	4.65e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ADCY5—osteoporosis	8.21e-06	4.62e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—GPX1—osteoporosis	8.18e-06	4.6e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IRS1—osteoporosis	8.13e-06	4.58e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IRS1—osteoporosis	8.12e-06	4.57e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ADCY5—osteoporosis	8.01e-06	4.51e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IRS1—osteoporosis	7.99e-06	4.49e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—GPX1—osteoporosis	7.98e-06	4.49e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—POMC—osteoporosis	7.96e-06	4.48e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—POMC—osteoporosis	7.83e-06	4.41e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CYP19A1—osteoporosis	7.83e-06	4.4e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—POMC—osteoporosis	7.83e-06	4.4e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—POMC—osteoporosis	7.82e-06	4.4e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—POMC—osteoporosis	7.81e-06	4.39e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—POMC—osteoporosis	7.78e-06	4.38e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6R—osteoporosis	7.77e-06	4.37e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IRS2—osteoporosis	7.73e-06	4.35e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—IL6—osteoporosis	7.73e-06	4.35e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—POMC—osteoporosis	7.69e-06	4.33e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IGF1—osteoporosis	7.66e-06	4.31e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—IL6—osteoporosis	7.65e-06	4.31e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6R—osteoporosis	7.64e-06	4.3e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6R—osteoporosis	7.62e-06	4.29e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—LEP—osteoporosis	7.57e-06	4.26e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ENO1—osteoporosis	7.56e-06	4.25e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ADCY5—osteoporosis	7.55e-06	4.25e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—MTHFR—osteoporosis	7.55e-06	4.25e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IGF1—osteoporosis	7.53e-06	4.24e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—GPX1—osteoporosis	7.52e-06	4.23e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—POMC—osteoporosis	7.52e-06	4.23e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—POMC—osteoporosis	7.52e-06	4.23e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IGF1—osteoporosis	7.52e-06	4.23e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—IL6—osteoporosis	7.5e-06	4.22e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6R—osteoporosis	7.5e-06	4.22e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IRS2—osteoporosis	7.48e-06	4.21e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IRS2—osteoporosis	7.48e-06	4.21e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL1B—osteoporosis	7.46e-06	4.2e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PSMA2—osteoporosis	7.45e-06	4.19e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PSMA5—osteoporosis	7.45e-06	4.19e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IGF1—osteoporosis	7.4e-06	4.16e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—MTHFR—osteoporosis	7.37e-06	4.15e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—LEP—osteoporosis	7.32e-06	4.12e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—LEP—osteoporosis	7.32e-06	4.12e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—IL6—osteoporosis	7.26e-06	4.08e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—IL6—osteoporosis	7.26e-06	4.08e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ESR1—osteoporosis	7.23e-06	4.07e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL1B—osteoporosis	7.22e-06	4.06e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL1B—osteoporosis	7.22e-06	4.06e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—MYC—osteoporosis	7.18e-06	4.04e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TGFB1—osteoporosis	7.17e-06	4.03e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—MYC—osteoporosis	7.08e-06	3.98e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TGFB1—osteoporosis	7.06e-06	3.97e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ESR1—osteoporosis	6.99e-06	3.93e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ESR1—osteoporosis	6.99e-06	3.93e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—MTHFR—osteoporosis	6.94e-06	3.91e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IRS1—osteoporosis	6.75e-06	3.8e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—IL6—osteoporosis	6.67e-06	3.75e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IRS1—osteoporosis	6.53e-06	3.67e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IRS1—osteoporosis	6.53e-06	3.67e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—POMC—osteoporosis	6.5e-06	3.66e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ADCY5—osteoporosis	6.4e-06	3.6e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GPX1—osteoporosis	6.37e-06	3.59e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6R—osteoporosis	6.34e-06	3.57e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—POMC—osteoporosis	6.29e-06	3.54e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—POMC—osteoporosis	6.29e-06	3.54e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IGF1—osteoporosis	6.25e-06	3.52e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6R—osteoporosis	6.14e-06	3.45e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6R—osteoporosis	6.14e-06	3.45e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MYC—osteoporosis	6.07e-06	3.42e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TGFB1—osteoporosis	6.06e-06	3.41e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IGF1—osteoporosis	6.05e-06	3.4e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IGF1—osteoporosis	6.05e-06	3.4e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.04e-06	3.4e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—POMC—osteoporosis	6.04e-06	3.4e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MYC—osteoporosis	6.01e-06	3.38e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TGFB1—osteoporosis	6e-06	3.38e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—POMC—osteoporosis	5.89e-06	3.32e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—MTHFR—osteoporosis	5.88e-06	3.31e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL6—osteoporosis	5.86e-06	3.29e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL6—osteoporosis	5.76e-06	3.24e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL6—osteoporosis	5.75e-06	3.23e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL6—osteoporosis	5.66e-06	3.18e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—POMC—osteoporosis	5.55e-06	3.12e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL6—osteoporosis	5.4e-06	3.04e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MYC—osteoporosis	5.37e-06	3.02e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—TGFB1—osteoporosis	5.35e-06	3.01e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6—osteoporosis	5.32e-06	2.99e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MYC—osteoporosis	5.24e-06	2.95e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TGFB1—osteoporosis	5.23e-06	2.94e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—osteoporosis	5.19e-06	2.92e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—osteoporosis	5.19e-06	2.92e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—TGFB1—osteoporosis	5.18e-06	2.91e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—TGFB1—osteoporosis	5.18e-06	2.91e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ADCY5—osteoporosis	4.94e-06	2.78e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GPX1—osteoporosis	4.92e-06	2.77e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—osteoporosis	4.78e-06	2.69e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—POMC—osteoporosis	4.7e-06	2.65e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—osteoporosis	4.63e-06	2.6e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—osteoporosis	4.63e-06	2.6e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—osteoporosis	4.6e-06	2.59e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TGFB1—osteoporosis	4.59e-06	2.58e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—osteoporosis	4.56e-06	2.57e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—MTHFR—osteoporosis	4.54e-06	2.55e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—osteoporosis	4.53e-06	2.55e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—osteoporosis	4.52e-06	2.54e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—osteoporosis	4.52e-06	2.54e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TGFB1—osteoporosis	4.52e-06	2.54e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TGFB1—osteoporosis	4.51e-06	2.54e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—osteoporosis	4.45e-06	2.5e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TGFB1—osteoporosis	4.43e-06	2.5e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—osteoporosis	4.37e-06	2.46e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—osteoporosis	4.23e-06	2.38e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—osteoporosis	4.23e-06	2.38e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—osteoporosis	4.03e-06	2.27e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—osteoporosis	3.94e-06	2.22e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—osteoporosis	3.9e-06	2.2e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—osteoporosis	3.9e-06	2.2e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—osteoporosis	3.76e-06	2.11e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TGFB1—osteoporosis	3.75e-06	2.11e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—osteoporosis	3.64e-06	2.05e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—osteoporosis	3.64e-06	2.05e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—POMC—osteoporosis	3.63e-06	2.04e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TGFB1—osteoporosis	3.63e-06	2.04e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TGFB1—osteoporosis	3.63e-06	2.04e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—osteoporosis	3.46e-06	1.95e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—osteoporosis	3.4e-06	1.92e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—osteoporosis	3.4e-06	1.91e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—osteoporosis	3.34e-06	1.88e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—osteoporosis	2.83e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—osteoporosis	2.73e-06	1.54e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—osteoporosis	2.73e-06	1.54e-05	CbGpPWpGaD
